Invention Grant
- Patent Title: 9-substituted 8-oxoadenine compound
- Patent Title (中): 9-取代的8-氧代腺嘌呤化合物
-
Application No.: US14058064Application Date: 2013-10-21
-
Publication No.: US08969362B2Publication Date: 2015-03-03
- Inventor: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
- Applicant: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
- Applicant Address: SE Soedertaelje JP Osaka-shi
- Assignee: AstraZeneca Aktiebolag,Sumitomo Dainippon Pharma Co., Ltd.
- Current Assignee: AstraZeneca Aktiebolag,Sumitomo Dainippon Pharma Co., Ltd.
- Current Assignee Address: SE Soedertaelje JP Osaka-shi
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Priority: JP2004-093672 20040326
- Main IPC: A61K31/522
- IPC: A61K31/522 ; C07D473/18 ; A61K31/5377

Abstract:
The present invention provides an 8-oxoadenine compound having immunomodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group] or its pharmaceutically acceptable salt.
Public/Granted literature
- US20140045837A1 9-Substituted 8-Oxoadenine Compound Public/Granted day:2014-02-13
Information query
IPC分类: